Synapse - Works

Results (2236)

Instructional strategies to enhance dermoscopic image interpretation education: A review of the literature

Review

Tran, T.; Ternov, N. K.; Weber, J.; Barata, C.; Berry, E. G.; Doan, H. Q.; Marghoob, A. A.; Seiverling, E. V.; Sinclair, S.; Stein, J. A.; more...
Dermatology Practical & Conceptual (2022)

Fulltext@MSK | Save

Indications for digital monitoring of patients with multiple nevi: Recommendations from the International Dermoscopy Society

Journal Article

Russo, T.; Piccolo, V.; Moscarella, E.; Tschandl, P.; Kittler, H.; Paoli, J.; Lallas, A.; Braun, R. P.; Thomas, L.; Soyer, H. P.; more...
Dermatology Practical & Conceptual (2022)

Fulltext@MSK | Save

Targeting insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in metastatic, PIK3CA-mutant, hormone receptor-positive breast cancer

Meeting Abstract

Shen, S.; Salehi, E.; Farooki, A.; Flory, J.; Williams, D.; Carpio, A.; Chang, C.; Lacouture, M. E.; Andreopoulou, E.; Sardesai, S. D.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

The PROTECT Study: A phase II, open-label trial of prophylactic skin toxicity therapy with clindamycin and triamcinolone in patients with glioblastoma treated with tumor-treating fields

Meeting Abstract

Lacouture, M. E.; Ketosugbo, K.; Dusza, S. W.; Goldlust, S. A.; Kumthekar, P.; Iwamoto, F. M.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer

Meeting Abstract

Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A survey study of prevention and treatment patterns by academic and community oncologists for papulopustular, acneiform skin rash associated with epidermal growth factor receptor inhibitor (EGFRi) therapy

Meeting Abstract

Lacouture, M. E.; Anadkat, M. J.; Patel, A. B.; Marathe, O. S.; Webb, M. L.; Tyler, R. C.; Chen, L.; Wu, C.; Li, W.; Ju, J.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Oral minoxidil for the treatment of late alopecia in cancer survivors

Meeting Abstract

Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K.; Pan, A.; Dusza, S. W.; Kraehenbuehl, L.; Gajria, D.; Lake, D. E.; Bromberg, J.; Goldfarb, S. B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib

Meeting Abstract

Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Digital skin imaging applications, part II: A comprehensive survey of post-acquisition image utilization features and technology standards

Journal Article

Sun, M. D.; Kentley, J.; Wilson, B. W.; Soyer, H. P.; Curiel-Lewandrowski, C. N.; Rotemberg, V. M.; Halpern, A. C.; The ISIC Technique Working Group
Skin Research and Technology (2022)

Fulltext@MSK | Save

The long-term evolution of melanocytic nevi among high-risk adults

Journal Article

Reiter, O.; Kurtansky, N. R.; Musthaq, S. T.; Dusza, S.; Halpern, A. C.; Marchetti, M. A.; Marghoob, A. A.; Scope, A.; Rotemberg, V.
Journal of the European Academy of Dermatology and Venereology (2022)

Fulltext@MSK | Save